Skip to main content

AbbVie acquisitions in 2026: 1 reported deal

This page lists 1 reported deal involving AbbVie. The latest, on Aug 29, 2026: ad-hoc-news.de reported "Karuna Therapeutics stock steady with AbbVie deal and schizophrenia drug progress."

Public (ABBV)Pharmaceutical Manufacturing10,000+ employeesabbvie.comLinkedIn

Acquisitions · latest 1

Latest reported AbbVie deals

Signal API · MCP

Track AbbVie with the Signal API

One POST /v1/companies/enrich call with abbvie.com returns AbbVie acquisitions signals (news, sec-8k), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{
    "domain": "abbvie.com",
    "signal_types": ["news","sec-8k"],
    "signal_subtypes": ["acquires","merges_with","acquisitionAnnounced",
      "acquisitionCompleted"],
    "limit": 20
  }'

Same industry

Questions about AbbVie acquisitions

What deals has AbbVie been linked to?
This page lists 1 reported deal. The newest: Aug 29, 2026: Karuna Therapeutics stock steady with AbbVie deal and schizophrenia drug progress (ad-hoc-news.de).

Source. News reports and SEC 8-K filings about acquisitions and mergers.

Method. Stories about the same deal within 14 days merge into one row. Deal values show only when the source states them in USD.

Data as of .

How this data is built →Get it from the Signal API →